Sitting can up cancer risk by as much as 66%

Share this content:

the ONA take:

A recent study conducted by researchers at the the University of Regensburg, Germany, and published in the Journal of the National Cancer Institute (JNCI) strongly linked inactivity to increased cancer risk. 

Researchers Daniela Schmid, Ph.D., M.Sc., and Michael F. Leitzmann, M.D., Dr.P.H., of the Department of Epidemiology and Preventive Medicine, created a meta-analysis that included 43 observational studies and nearly 69 thousand cancer cases. Data in the individual studies was obtained with self-administered questionnaires and via interviews. The amount of sedimentary behavior for patients was recorded and reviewed. Their findings strongly link more sedimentary behavior with increased cancer risk for a variety of cancer types. They observed, with sedimentary behavior, a 32% higher risk of endometrial cancer, and a 21% increased risk of lung cancer, and a 24% greater risk of colon cancer development. Those individuals watching television during their sedimentary or sitting time faced greater increased risk, amounting to a 54% higher risk of colon cancer development and 66% higher endometrial cancer risk.

These finding highlight the importance of exercise and add to the dangers already know about prolonged sitting, which include great risk of obesity and blood sugar peak issues. Television viewing, perhaps because TV viewers eat more snacks, is also very detrimental.

Sitting can up cancer risk by as much as 66%
Sitting can up cancer risk by as much as 66%
By now we're pretty familiar with the biggest cancer-triggers in our lives – processed meats, smoking, and tumor-causing pollutants in the air, to name a few. But it turns out there's another hidden cancer contributor that occupies much of our daily lives: sitting.
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs